RWLK · Rewalk Robotics Ltd. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.92M | - | $6.20M | $5.72M | $5.03M | - | $6.13M | $6.71M | $5.28M | - |
| Cost of Revenue | $2.58M | - | $3.49M | $3.21M | $2.91M | - | $3.91M | $3.95M | $3.89M | - |
| Gross Profit | $1.34M | - | $2.71M | $2.51M | $2.12M | - | $2.22M | $2.76M | $1.40M | - |
| R&D | $5.84M | - | $721.0K | $767.0K | $918.0K | - | $998.0K | $1.21M | $1.29M | - |
| SG&A | $2.56M | - | $1.96M | $1.74M | $2.22M | - | $240.0K | $1.59M | $1.59M | - |
| Total Operating Expenses | $11.68M | - | $5.85M | $9.07M | $6.97M | - | $5.39M | $7.20M | $7.90M | - |
| D&A | $59.0K | - | - | - | $90.0K | - | - | - | $125.0K | - |
| Operating Income | ($10.34M) | - | ($3.14M) | ($6.56M) | ($4.85M) | - | ($3.17M) | ($4.44M) | ($6.50M) | - |
| Interest Expense | $416.0K | - | - | - | - | - | - | - | - | - |
| Income Tax | $6.0K | - | $7.0K | $0 | $11.0K | - | $29.0K | $5.0K | $6.0K | - |
| Net Income | ($10.79M) | - | ($3.17M) | ($6.56M) | ($4.83M) | - | ($3.08M) | ($4.30M) | ($6.28M) | - |
| EPS - Basic | ($6.70) | - | ($0.20) | ($0.58) | ($0.46) | - | ($0.35) | ($0.50) | ($0.73) | - |
| EPS - Diluted | ($6.70) | - | ($0.20) | ($0.58) | ($0.46) | - | ($0.35) | ($0.50) | ($0.73) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.42M | $2.17M | $1.96M | $5.14M | $5.73M | $6.75M | $10.65M | $15.13M | $20.74M | $28.08M |
| Accounts Receivable | $5.66M | $6.14M | $6.13M | $5.86M | $5.17M | $6.00M | $5.84M | $5.27M | $3.49M | $3.12M |
| Inventory | $6.25M | $5.73M | $7.11M | $7.62M | $6.80M | $6.72M | $7.30M | $7.19M | $6.06M | $5.65M |
| Accounts Payable | $6.38M | $5.59M | $5.25M | $6.11M | $4.47M | $5.02M | $4.99M | $4.85M | $4.28M | $5.07M |
| Current Assets | $25.56M | $15.81M | $17.35M | $20.71M | $19.82M | $21.29M | $25.61M | $29.64M | $32.79M | $39.22M |
| Total Assets | $33.42M | $22.90M | $23.17M | $26.78M | $28.81M | $30.49M | $45.77M | $50.98M | $55.22M | $63.19M |
| Current Liabilities | $10.63M | $12.04M | $9.05M | $10.36M | $9.07M | $10.22M | $9.66M | $9.97M | $10.09M | $11.79M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $27.13M | $14.49M | $10.41M | $11.67M | $10.35M | $11.64M | $11.88M | $14.30M | $14.60M | $16.68M |
| Stockholders' Equity | $6.29M | $8.41M | $12.76M | $15.11M | $18.46M | $18.85M | $33.89M | $36.69M | $40.62M | $46.51M |
| Retained Earnings | ($295.53M) | ($284.74M) | ($279.39M) | ($276.22M) | ($269.66M) | ($264.82M) | ($249.55M) | ($246.46M) | ($242.16M) | ($235.88M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($3.67M) | - | - | - | ($5.49M) | - | - | - | ($7.67M) | - |
| Investing Cash Flow | $6.50M | - | - | - | ($5.0K) | - | - | - | $0 | - |
| Financing Cash Flow | $6.42M | - | - | - | $4.47M | - | - | - | $0 | - |
| CapEx | $0 | - | - | - | $5.0K | - | - | - | $0 | - |
| Free Cash Flow | ($3.67M) | - | - | - | ($5.50M) | - | - | - | ($7.67M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 34.2% | - | 43.7% | 43.9% | 42.2% | - | 36.2% | 41.1% | 26.4% | - |
| Operating margin | -263.5% | - | -50.7% | -114.7% | -96.4% | - | -51.8% | -66.2% | -123.1% | - |
| EBITDA margin | -262.0% | - | - | - | -94.6% | - | - | - | -120.7% | - |
| Net margin | -275.1% | - | -51.2% | -114.6% | -96.0% | - | -50.3% | -64.2% | -118.8% | - |
| Free cash flow margin | -93.7% | - | - | - | -109.2% | - | - | - | -145.2% | - |
| FCF / Net income | 0.34 | - | - | - | 1.14 | - | - | - | 1.22 | - |
| R&D / Revenue | 149.0% | - | 11.6% | 13.4% | 18.2% | - | 16.3% | 18.0% | 24.4% | - |
| SG&A / Revenue | 65.4% | - | 31.6% | 30.4% | 44.1% | - | 3.9% | 23.7% | 30.1% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -32.3% | - | -13.7% | -24.5% | -16.8% | - | -6.7% | -8.4% | -11.4% | - |
| Return on equity | -171.6% | - | -24.9% | -43.4% | -26.2% | - | -9.1% | -11.7% | -15.5% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.40 | 1.31 | 1.92 | 2.00 | 2.18 | 2.08 | 2.65 | 2.97 | 3.25 | 3.33 |
| Quick ratio | 1.82 | 0.84 | 1.13 | 1.26 | 1.43 | 1.43 | 1.90 | 2.25 | 2.65 | 2.85 |
| Cash ratio | 1.07 | 0.18 | 0.22 | 0.50 | 0.63 | 0.66 | 1.10 | 1.52 | 2.06 | 2.38 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -24.9x | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 5.31 | 2.72 | 1.82 | 1.77 | 1.56 | 1.62 | 1.35 | 1.39 | 1.36 | 1.36 |
| Liabilities / Assets | 0.81 | 0.63 | 0.45 | 0.44 | 0.36 | 0.38 | 0.26 | 0.28 | 0.26 | 0.26 |
| Efficiency | ||||||||||
| Asset turnover | 0.12 | - | 0.27 | 0.21 | 0.17 | - | 0.13 | 0.13 | 0.10 | - |
| Inventory turnover | 0.41 | - | 0.49 | 0.42 | 0.43 | - | 0.54 | 0.55 | 0.64 | - |
| Days sales outstanding | 527d | - | 361d | 374d | 374d | - | 348d | 287d | 241d | - |
| Days inventory outstanding | 884d | - | 744d | 866d | 853d | - | 682d | 665d | 569d | - |
| Days payable outstanding | 902d | - | 549d | 694d | 560d | - | 466d | 448d | 402d | - |
| Cash conversion cycle | 509d | - | 556d | 545d | 667d | - | 564d | 503d | 408d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -22.1% | - | 1.1% | -14.7% | -4.7% | - | 39.2% | 401.6% | 329.5% | - |
| Revenue CAGR (3y) | 47.2% | - | 91.2% | 53.9% | 79.1% | - | 45.9% | 67.2% | 58.9% | - |
| Revenue CAGR (5y) | 24.4% | - | 52.7% | 28.0% | 46.0% | - | 37.8% | 50.2% | 27.3% | - |
| Gross profit growth (YoY) | -36.8% | - | 21.9% | -8.9% | 52.1% | - | 157.2% | 378.6% | 144.3% | - |
| Operating income growth (YoY) | -113.0% | - | 1.1% | -47.7% | 25.4% | - | 60.0% | 13.9% | -48.6% | - |
| Net income growth (YoY) | -123.3% | - | -2.8% | -52.5% | 23.0% | - | 59.0% | 7.3% | -45.2% | - |
| EPS growth (YoY) | -1356.5% | - | 42.9% | -16.0% | 37.0% | - | -169.2% | -525.0% | -942.9% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 33.2% | - | - | - | 28.3% | - | - | - | -46.6% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -65.9% | -55.4% | -62.4% | -58.8% | -54.6% | -59.5% | -34.5% | -37.8% | -36.1% | -31.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$22.03M totalProduct$17.16M · 77.9%
Service And Warranty$3.09M · 14.0%
Lease Of Products$1.78M · 8.1%
Geographic
$22.03M totalUS$13.24M · 60.1%
DE$4.01M · 18.2%
Europe$2.91M · 13.2%
Rest Of World$1.42M · 6.4%
Asia Pacific$460.0K · 2.1%
Peer comparison
Same SIC group: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Comparing ReWalk Robotics Ltd. against the 5 most active filers in the same SIC group.